arrow
S

Sanbin Wang

920th hospital of joint logistics support force of people's liberation army of china
H指数:15
被引数:889

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A real-world, multi-center, retrospective study of autologous hematopoietic stem cell transplantation in 33 patients with HIV-associated lymphoma in China (CALL-006 Study)

中国33例人类免疫缺陷病毒相关淋巴瘤患者自体造血干细胞移植的多中心、回顾性真实世界研究(CALL-006研究)

2026-08-190
PRE
Venetoclax plus azacitidine, low-dose cytarabine, aclarubicin, and G-CSF (VA-CAG regimen) for newly diagnosed young patients with acute myeloid leukemia: A prospective, multicenter, single-arm Phase II clinical trial

维奈克拉联合阿扎胞苷、低剂量阿糖胞苷、阿克拉霉素和G-CSF(VA-CAG方案)用于新诊断年轻急性髓系白血病患者的治疗:一项前瞻性、多中心、单臂II期临床试验

2026-08-120
OAAI
Incidence and risk factors for graft failure after allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

异基因造血干细胞移植后骨髓纤维化患者的移植物失败发生率和危险因素

2025-11-010
PRE
Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system
2024-12-120
OAAI
Current situation and development of hematopoietic cell transplantation centers: A nationwide survey in China
2024-01-220
OAAI
CD7 targeted off-the-shelf CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies
LEUKEMIA
IF13.4
2023-09-129
PRE
Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of prime CAR-T
2023-06-016
OAAI
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study
CANCER
IF5.1
2023-03-238
PRE
Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing
2022-06-074
OAAI
Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management

通过CD7-targeted通用car-t细胞根除t-all细胞,并对基于Ruxolitinib的CRS管理进行初步测试

2021-03-0173
OAAI